BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27343306)

  • 1. Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
    Gungor T; Cetinkaya N; Yalcin H; Zergeroglu S; Erkaya S
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):309-13. PubMed ID: 27343306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol.
    Zhao X; Niu J; Shi C; Liu Z
    Reprod Health; 2022 Nov; 19(1):206. PubMed ID: 36333773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM; Novikova OV; Andreeva JY; Novikova EG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
    Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
    Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
    Nucera G; Mandato VD; Gelli MC; Palomba S; La Sala GB
    Gynecol Endocrinol; 2013 Mar; 29(3):219-21. PubMed ID: 23153053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
    Laurelli G; Falcone F; Scaffa C; Messalli EM; Del Giudice M; Losito S; Greggi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():61-66. PubMed ID: 26476800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer.
    Hwang JY; Kim DH; Bae HS; Kim ML; Jung YW; Yun BS; Seong SJ; Shin E; Kim MK
    Int J Gynecol Cancer; 2017 May; 27(4):738-742. PubMed ID: 28346240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis.
    Fan Z; Li H; Hu R; Liu Y; Liu X; Gu L
    Int J Gynecol Cancer; 2018 Feb; 28(2):385-393. PubMed ID: 29266019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
    Park JY; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
    Obstet Gynecol; 2013 Jan; 121(1):136-42. PubMed ID: 23262938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.
    Ricciardi E; Maniglio P; Frega A; Marci R; Caserta D; Moscarini M
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1934-7. PubMed ID: 23242719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
    Shan BE; Ren YL; Sun JM; Tu XY; Jiang ZX; Ju XZ; Zang RY; Wang HY
    Arch Gynecol Obstet; 2013 Nov; 288(5):1115-23. PubMed ID: 23644919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
    Novikova OV; Nosov VB; Panov VA; Novikova EG; Krasnopolskaya KV; Andreeva YY; Shevchuk AS
    Gynecol Oncol; 2021 Apr; 161(1):152-159. PubMed ID: 33461741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial adenocarcinoma in young-aged women: a Turkish population study.
    Gungor T; Cetinkaya N; Ozdal B; Yalcin H; Erkaya S; Yakut HI
    Eur J Gynaecol Oncol; 2015; 36(6):667-71. PubMed ID: 26775348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.
    Han AR; Kwon YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2009 Jan; 19(1):147-51. PubMed ID: 19258957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.
    Kim MK; Seong SJ; Song T; Kim ML; Yoon BS; Jun HS; Lee GH; Lee YH
    Gynecol Oncol; 2013 Sep; 130(3):470-3. PubMed ID: 23822890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
    Giampaolino P; Di Spiezio Sardo A; Mollo A; Raffone A; Travaglino A; Boccellino A; Zizolfi B; Insabato L; Zullo F; De Placido G; Bifulco G
    J Minim Invasive Gynecol; 2019; 26(4):648-656. PubMed ID: 30017893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved.
    Perri T; Korach J; Gotlieb WH; Beiner M; Meirow D; Friedman E; Ferenczy A; Ben-Baruch G
    Int J Gynecol Cancer; 2011 Jan; 21(1):72-8. PubMed ID: 21178572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.